News
Give a monthly donation to help us stay one step ahead of cancer with new smarter and targeted treatments – so that more people will survive blood cancer. Cecelia Brunott (pictured above) was ...
A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial.
A new type of liquid biopsy test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research by a team from The Institute of Cancer Research, ...
The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...
The overuse of CT scans could cause over 100,000 cases of cancer in the US – with almost 10,000 cases in children, researchers have warned.
A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results ...
Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer. IBD includes ...
The latest major breakthrough in cancer is a drug called capivasertib, which has shown ‘remarkable’ results against advanced breast cancer in its first phase III trial.
Doctors could soon be able to better predict an individual patient’s chances of getting cancer and offer them personalised detection and prevention strategies, thanks to a new research project co-led ...
ASCO 2025: AI test determines best prostate cancer treatment – which could save NHS moneyA new AI test can pick out which men with high-risk prostate cancer that has not spread will require ...
Scientists discover the ‘roadmap’ that aggressive cancer uses to spread around the body – identifying ways to block its escapeImage of human melanoma tissue, with melanoma cells in green and purple ...
A pioneering research study which will allow brain cancer patients to access drugs that are precisely targeted to their disease and swap to different treatments if needed, has launched in the UK. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results